生命科学资讯

10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Rate Hike: Can 10x Genomics Inc grow without dilution - July 2025 Summary & High Return Trade Guides - baoquankhu1.vn

UPC Clarifies PI Costs Breakdown In mRNA Fight - Law360

Foundations Investment Advisors LLC Takes Position in 10x Genomics $TXG - MarketBeat

10x Genomics $TXG Holdings Decreased by Federated Hermes Inc. - MarketBeat

Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in 10x Genomics $TXG - MarketBeat

AlphaQuest LLC Increases Holdings in 10x Genomics $TXG - MarketBeat

Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance

Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit - Genetic Engineering and Biotechnology News

Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature

4 Best Genetic Sequencing Stocks To Buy in 2026 - The Motley Fool

Breaking Down 10x Genomics: 13 Analysts Share Their Views - Benzinga

Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb

Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com

Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com

Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st

A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st

10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st

10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st